Table 3.
Formulations | Pharmacokinetic parameters | ||||||
---|---|---|---|---|---|---|---|
Cmax (U/ml) | Tmax (h) | AUC0-24 (U.h/ml) | AUMC0-24 | T1/2 (h) | MRT (h) | Frelative (%) | |
Plain LMWH Subcutaneous | 0.33±0.03 | 4.4±0.31 | 3.98±0.22 | 36.6±1.72 | 4.35±0.33 | 7.79±0.60 | ---- |
Plain LMWH pulmonary | 0.20±0.01 | 2.2±0.44 | 1.58±0.12 | 9.63±0.77 | 4.28±0.31 | 6.63±0.47 | 39.7±3.0 |
PM-2 | 0.07±0.04 | 0.8±0.4 | 1.05±0.11 | 10.57±2.04 | 12.13±0.93 | 18.43±1.42 | 26.38±2.8 |
PM-SP-2 | 0.13±0.03 | 1.7±0.3 | 1.98±0.29 | 21.22±1.86 | 23.75±2.97 | 34.33±4.29 | 49.74±7.31 |
PM-SA-2 | 0.20±0.04 | 6.9±0.89 | 3.64±0.36 | 43.14±3.7 | 25.28±2.81 | 39.09±4.34 | 91.45±9.01 |
PM-PEI-2 | 0.21±0.03 | 7.6±0.70 | 3.37±0.40 | 40.8±2.38 | 20.13±1.68 | 32.39±2.70 | 84.67±10.11 |
SEM: Standard error of the mean